Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18069 | 568 | 33.6 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
192 | 3 | GASTROESOPHAGEAL REFLUX DISEASE//GASTROESOPHAGEAL REFLUX//ESOPHAGEAL CANCER | 54156 |
531 | 2 | GASTROESOPHAGEAL REFLUX DISEASE//GASTROESOPHAGEAL REFLUX//PROTON PUMP INHIBITORS | 14930 |
18069 | 1 | PROTON PUMP INHIBITORS//OMEPRAZOLE//HYPOMAGNESEMIA | 568 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PROTON PUMP INHIBITORS | authKW | 1152194 | 39% | 10% | 221 |
2 | OMEPRAZOLE | authKW | 130422 | 11% | 4% | 62 |
3 | HYPOMAGNESEMIA | authKW | 75112 | 4% | 6% | 24 |
4 | ACID SUPPRESSIVE MEDICATIONS | authKW | 71676 | 0% | 67% | 2 |
5 | PANTOPRAZOLE | authKW | 62678 | 4% | 6% | 21 |
6 | ABERDEEN CITY COMMUNITY HLTH PARTNERSHIP | address | 53758 | 0% | 100% | 1 |
7 | ACID SECRETIONS | authKW | 53758 | 0% | 100% | 1 |
8 | ACID SUPPRESSING DRUG | authKW | 53758 | 0% | 100% | 1 |
9 | ACID SUPPRESSION MEDICATIONS | authKW | 53758 | 0% | 100% | 1 |
10 | ADVERSE EFFECT OF DRUGS | authKW | 53758 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 3198 | 23% | 0% | 131 |
2 | Medicine, General & Internal | 1043 | 21% | 0% | 118 |
3 | Pharmacology & Pharmacy | 959 | 26% | 0% | 145 |
4 | Primary Health Care | 372 | 3% | 0% | 15 |
5 | Endocrinology & Metabolism | 258 | 9% | 0% | 53 |
6 | Geriatrics & Gerontology | 257 | 4% | 0% | 22 |
7 | Public, Environmental & Occupational Health | 34 | 5% | 0% | 26 |
8 | Urology & Nephrology | 33 | 3% | 0% | 17 |
9 | Nutrition & Dietetics | 33 | 3% | 0% | 15 |
10 | Gerontology | 27 | 1% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABERDEEN CITY COMMUNITY HLTH PARTNERSHIP | 53758 | 0% | 100% | 1 |
2 | BONE METAB UNITENDOCRINOL | 53758 | 0% | 100% | 1 |
3 | CARDIOVASC MED VASC SURG | 53758 | 0% | 100% | 1 |
4 | CATEDRA MICROBIOL MED | 53758 | 0% | 100% | 1 |
5 | CHEM PHYSIOL MOL EXPT MED | 53758 | 0% | 100% | 1 |
6 | CLIN PHARMACOLHLTH IDIPAZ | 53758 | 0% | 100% | 1 |
7 | CLIN SOCIAL ADM SCI PHARM OUTCOMES | 53758 | 0% | 100% | 1 |
8 | COLINDALE REFERENCE MICROBIOL SERV | 53758 | 0% | 100% | 1 |
9 | COM EXCELENCIA CLIN | 53758 | 0% | 100% | 1 |
10 | CONTRADA MUOIO PICCOLO SNC | 53758 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 6539 | 5% | 0% | 28 |
2 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2799 | 2% | 0% | 11 |
3 | EUROPEAN JOURNAL OF GENERAL PRACTICE | 1862 | 1% | 1% | 3 |
4 | AUSTRALIAN PRESCRIBER | 1510 | 0% | 1% | 2 |
5 | THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 1015 | 0% | 1% | 2 |
6 | JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION | 966 | 1% | 0% | 5 |
7 | CALCIFIED TISSUE INTERNATIONAL | 888 | 2% | 0% | 9 |
8 | OSTEOPOROSIS INTERNATIONAL | 872 | 2% | 0% | 9 |
9 | ANNALS OF PHARMACOTHERAPY | 795 | 2% | 0% | 9 |
10 | AMERICAN JOURNAL OF THERAPEUTICS | 771 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROTON PUMP INHIBITORS | 1152194 | 39% | 10% | 221 | Search PROTON+PUMP+INHIBITORS | Search PROTON+PUMP+INHIBITORS |
2 | OMEPRAZOLE | 130422 | 11% | 4% | 62 | Search OMEPRAZOLE | Search OMEPRAZOLE |
3 | HYPOMAGNESEMIA | 75112 | 4% | 6% | 24 | Search HYPOMAGNESEMIA | Search HYPOMAGNESEMIA |
4 | ACID SUPPRESSIVE MEDICATIONS | 71676 | 0% | 67% | 2 | Search ACID+SUPPRESSIVE+MEDICATIONS | Search ACID+SUPPRESSIVE+MEDICATIONS |
5 | PANTOPRAZOLE | 62678 | 4% | 6% | 21 | Search PANTOPRAZOLE | Search PANTOPRAZOLE |
6 | ACID SECRETIONS | 53758 | 0% | 100% | 1 | Search ACID+SECRETIONS | Search ACID+SECRETIONS |
7 | ACID SUPPRESSING DRUG | 53758 | 0% | 100% | 1 | Search ACID+SUPPRESSING+DRUG | Search ACID+SUPPRESSING+DRUG |
8 | ACID SUPPRESSION MEDICATIONS | 53758 | 0% | 100% | 1 | Search ACID+SUPPRESSION+MEDICATIONS | Search ACID+SUPPRESSION+MEDICATIONS |
9 | ADVERSE EFFECT OF DRUGS | 53758 | 0% | 100% | 1 | Search ADVERSE+EFFECT+OF+DRUGS | Search ADVERSE+EFFECT+OF+DRUGS |
10 | ANACIDITY | 53758 | 0% | 100% | 1 | Search ANACIDITY | Search ANACIDITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DE LA COBA, C , ARGUELLES-ARIAS, F , DE ARGILA, CM , JUDEZ, J , LINARES, A , ORTEGA-ALONSO, A , RODRIGUEZ, E , RODRIGUEZ-TELLEZ, M , VERA, I , AGUILERA, L , ET AL (2016) ADVERSE EFFECTS OF THE PROTON PUMP INHIBITORS: REVIEW OF EVIDENCES AND POSITION OF THE SPANISH SOCIETY OF DIGESTIVE PATHOLOGY.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS. VOL. 108. ISSUE 4. P. 207 -224 | 66 | 48% | 1 |
2 | ZHOU, B , HUANG, Y , LI, H , SUN, W , LIU, J , (2016) PROTON-PUMP INHIBITORS AND RISK OF FRACTURES: AN UPDATE META-ANALYSIS.OSTEOPOROSIS INTERNATIONAL. VOL. 27. ISSUE 1. P. 339 -347 | 27 | 75% | 7 |
3 | WILHELM, SM , RJATER, RG , KALE-PRADHAN, PB , (2013) PERILS AND PITFALLS OF LONG-TERM EFFECTS OF PROTON PUMP INHIBITORS.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 6. ISSUE 4. P. 443-451 | 44 | 59% | 23 |
4 | ANDERSEN, BN , JOHANSEN, PB , ABRAHAMSEN, B , (2016) PROTON PUMP INHIBITORS AND OSTEOPOROSIS.CURRENT OPINION IN RHEUMATOLOGY. VOL. 28. ISSUE 4. P. 420 -425 | 21 | 88% | 2 |
5 | CAI, DW , FENG, W , JIANG, Q , (2015) ACID-SUPPRESSIVE MEDICATIONS AND RISK OF FRACTURE: AN UPDATED META-ANALYSIS.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. VOL. 8. ISSUE 6. P. 8893 -8904 | 28 | 76% | 1 |
6 | JANETT, S , CAMOZZI, P , PEETERS, GGAM , LAVA, SAG , SIMONETTI, GD , SIMONETTI, BG , BIANCHETTI, MG , MILANI, GP , (2015) HYPOMAGNESEMIA INDUCED BY LONG-TERM TREATMENT WITH PROTON-PUMP INHIBITORS.GASTROENTEROLOGY RESEARCH AND PRACTICE. VOL. . ISSUE . P. - | 25 | 81% | 2 |
7 | YU, EW , BAUER, SR , BAIN, PA , BAUER, DC , (2011) PROTON PUMP INHIBITORS AND RISK OF FRACTURES: A META-ANALYSIS OF 11 INTERNATIONAL STUDIES.AMERICAN JOURNAL OF MEDICINE. VOL. 124. ISSUE 6. P. 519 -526 | 23 | 64% | 92 |
8 | BAHTIRI, E , ISLAMI, H , HOXHA, R , QORRAJ-BYTYQI, H , REXHEPI, S , HOTI, K , THACI, K , THACI, S , KARAKULAK, C , (2016) ESOMEPRAZOLE USE IS INDEPENDENTLY ASSOCIATED WITH SIGNIFICANT REDUCTION OF BMD: 1-YEAR PROSPECTIVE COMPARATIVE SAFETY STUDY OF FOUR PROTON PUMP INHIBITORS.JOURNAL OF BONE AND MINERAL METABOLISM. VOL. 34. ISSUE 5. P. 571 -579 | 22 | 63% | 2 |
9 | TARGOWNIK, LE , LESLIE, WD , DAVISON, KS , GOLTZMAN, D , JAMAL, SA , KREIGER, N , JOSSE, RG , KAISER, SM , KOVACS, CS , PRIOR, JC , ET AL (2012) THE RELATIONSHIP BETWEEN PROTON PUMP INHIBITOR USE AND LONGITUDINAL CHANGE IN BONE MINERAL DENSITY: A POPULATION-BASED FROM THE CANADIAN MULTICENTRE OSTEOPOROSIS STUDY (CAMOS).AMERICAN JOURNAL OF GASTROENTEROLOGY. VOL. 107. ISSUE 9. P. 1361-1369 | 22 | 69% | 31 |
10 | HINSON, AM , WILKERSON, BM , ROTHMAN-FITTS, I , RIGGS, AT , STACK, BC , BODENNER, DL , (2015) HYPERPARATHYROIDISM ASSOCIATED WITH LONG-TERM PROTON PUMP INHIBITORS INDEPENDENT OF CONCURRENT BISPHOSPHONATE THERAPY IN ELDERLY ADULTS.JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. VOL. 63. ISSUE 10. P. 2070 -2073 | 18 | 82% | 4 |
Classes with closest relation at Level 1 |